Immunome Inc. Research And Development Expense

• Immunome Inc. showed an increase of +36.9% in Research And Development Expense from 2024 to 2025.
• This data is from Immunome Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), Immunome Inc.'s Research And Development Expense has grown by 1,909.4%.
• Historical annual values: Fiscal year 2025: $177.29 million | Fiscal year 2024: $129.54 million | Fiscal year 2023: $23.09 million | Fiscal year 2022: $23.27 million | Fiscal year 2021: $14.11 million | Fiscal year 2020: $7.49 million | Fiscal year 2019: $8.82 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026